name:-0.0027990341186523
name:-0.037261962890625
name:-0.00067305564880371
A NATTERMANN & CIE GMBH Patent Filings

A NATTERMANN & CIE GMBH

Patent Applications and Registrations

Patent applications and USPTO patent grants for A NATTERMANN & CIE GMBH.The latest application filed is for "alcohol-free pharmaceutical composition comprising thyme and primula root liquid extracts".

Company Profile
0.35.1
  • A NATTERMANN & CIE GMBH - Koeln DE
  • A. Nattermann & Cie GmbH - Cologne DE
  • A. Nattermann & Cie. GmbH - K oln DE
  • A. Nattermann & CIE GmbH - DE DE
  • A. Nattermann & Cie, GmbH - Koln DE
  • A. Nattermann & Cie. GmbH - Nattermannallee DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Alcohol-free Pharmaceutical Composition Comprising Thyme And Primula Root Liquid Extracts
App 20140072661 - Hoffmann; Verena ;   et al.
2014-03-13
Water-containing liposome system
Grant 5,741,517 - Hager , et al. April 21, 1
1998-04-21
Water containing liposome system
Grant 5,556,637 - Hager , et al. September 17, 1
1996-09-17
Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same
Grant 5,288,734 - Hager , et al. February 22, 1
1994-02-22
Solid drug preparations containing micronized crystals of ebselen
Grant 5,021,242 - Romer , et al. June 4, 1
1991-06-04
Process for producing ebselen in highly pure form
Grant 5,008,394 - Gunther , et al. April 16, 1
1991-04-16
Device and process for marking molded items and tablets with laser beams
Grant 4,906,813 - Gajdos March 6, 1
1990-03-06
Process for the treatment of inflammatory and allergic diseases
Grant 4,784,994 - Romer , et al. November 15, 1
1988-11-15
Benzisoselenazolonyl derivatives and processes for the treatment of rheumatic disease
Grant 4,774,252 - Welter , et al. September 27, 1
1988-09-27
Process for the treatment of diseases caused by oxidative stress
Grant 4,757,063 - Parnham July 12, 1
1988-07-12
Imidazole group containing 2(1H)-pyridones and method for treating heart insufficiencies in humans
Grant 4,699,914 - Hilboll , et al. October 13, 1
1987-10-13
Formulation with special 1,2-diacylglycero-3-phosphocholines for the treatment of gastrointestinal disorders
Grant 4,684,632 - Schulz , et al. August 4, 1
1987-08-04
Phospholipid compositions and their use in plant protection spray mixtures
Grant 4,681,617 - Ghyczy , et al. July 21, 1
1987-07-21
Substituted 6-(thien-2-yl)-3(2H)-pyridazinones
Grant 4,667,033 - Hilboll , et al. * May 19, 1
1987-05-19
1,4,5-triphenylimidazol-2-yl mercapto alkanoic acids, useful against inflammation and diseases responding to lipid lowering
Grant 4,654,358 - Lautenschlager , et al. * March 31, 1
1987-03-31
Benzisoselenazolones and a process for the treatment of inflammatory diseases
Grant 4,550,168 - Welter , et al. October 29, 1
1985-10-29
Process for filling pharmaceutical products containing phospholipides and highly viscous at room temperature, into hard capsules
Grant 4,497,157 - Durr , et al. February 5, 1
1985-02-05
Phospholipid solutions
Grant 4,482,474 - Biedermann , et al. November 13, 1
1984-11-13
Indol acetic acid derivatives and anti-inflamatory and related uses thereof
Grant 4,464,379 - Betzing , et al. August 7, 1
1984-08-07
Triphenylimidazolyloxyalkanoic acids and their derivatives and a process for the treatment of thromboembolic, inflammatory and/or atheriosclerotic diseases
Grant 4,460,598 - Lautenschlager , et al. July 17, 1
1984-07-17
Cycloalkyl derivatives of benzisoselenazolones
Grant 4,454,068 - Welter , et al. June 12, 1
1984-06-12
Process for the separation of oils and/or phosphatidylethanolamine from alcohol soluble phosphatidylcholine products containing the same
Grant 4,452,743 - Gunther * June 5, 1
1984-06-05
(+)-2-[1-(2,6-Dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene and the method for the treatment of human beings suffering from nervous disarrangements, in particular migraine
Grant 4,443,464 - Biedermann , et al. April 17, 1
1984-04-17
Inflammation-preventing pharmaceutical composition of oral administration
Grant 4,421,747 - Ghyczy , et al. December 20, 1
1983-12-20
Benzisoselenazolones and process for the treatment of rheumatic and arthritic diseases using them
Grant 4,418,069 - Welter , et al. November 29, 1
1983-11-29
Inflammation-preventing pharmaceutical composition of oral administration
Grant 4,378,354 - Ghyczy , et al. March 29, 1
1983-03-29
Inflammation-preventing pharmaceutical composition of oral administration
Grant 4,369,182 - Ghyczy , et al. January 18, 1
1983-01-18
Inflammation-preventing pharmaceutical composition of oral administration
Grant 4,332,795 - Ghyczy , et al. June 1, 1
1982-06-01
Stable injectable solutions of indoleacetic acid derivatives
Grant 4,309,420 - Ghyczy , et al. January 5, 1
1982-01-05
Stabilized parenterally administrable solutions
Grant 4,309,421 - Ghyczy , et al. January 5, 1
1982-01-05
N-Propionylsarcosineanilides, process for their preparation, and pharmaceutical compositions containing them
Grant 4,303,673 - Biedermann , et al. December 1, 1
1981-12-01
Process to obtain oily, highly purified phosphatidylcholines
Grant 4,235,793 - Betzing November 25, 1
1980-11-25
Benzoylethers and processes for their production
Grant 4,140,770 - Repplinger , et al. February 20, 1
1979-02-20
Process of manufacturing enzyme preparation rich in lipase
Grant 4,088,539 - Muller May 9, 1
1978-05-09
Process of manufacturing enzyme preparation rich in lipase
Grant 3,925,158 - Betzing , et al. December 9, 1
1975-12-09
Glycol Phosphatides And The Preparation Thereof From Cephalin
Grant 3,681,412 - Betzing August 1, 1
1972-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed